[ad_1] In pharma, you can take a larger slice of the healthcare pie than your peers, but you are still constrained by the size of the pie. No matter how…
Tag: BMY
Bristol-Myers Squibb to Buy RayzeBio for $4.1 Billion
[ad_1] Updated Dec. 26, 2023 12:33 pm ET Drug company Bristol-Myers Squibb struck a $4.1 billion deal to buy RayzeBio, in a bet on a re-emerging cancer drug technology. RayzeBio…
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
[ad_1] The deal expands the pharmaceutical company’s portfolio of cancer drugs. [ad_2] Source link
The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out
[ad_1] What to Read Next [ad_2] Source link
Blockbuster Cancer Treatment Stymied by Supply Chain—for Now
[ad_1] A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing. [ad_2] Source link
Big Pharma’s Battle With the Biden Administration Could Have Legs
[ad_1] Wall Street should pay attention as the pharma industry mounts a widening legal campaign against the Inflation Reduction Act. [ad_2] Source link
He Was a Scientist. Could He Find a Drug to Treat His Own Disease?
[ad_1] How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” [ad_2] Source link
BUSINESS CLOSE: Entain set for HMRC penalty
[ad_1] BUSINESS CLOSE: Ladbrokes owner set for ‘substantial’ HMRC penalty; B&M boosts profit expectations; WH Smith lifted by travel rebound By Live Commentary Updated: 17:15 31 May 2023 Some links…